MaxVal Blog

    Filter by Category
    Filter by Category

    Go Back to Homepage

    Technology Landscape Study on CRISPR-Cas9

    CRISPR-Cas9

    Although CRISPR was known to have an important role in bacterial immunity for over a decade, it is only in the last 5 years that it has garnered interest as a gene editing tool. Increasing investment in this field is indicative of global market opportunities for CRISPR-Cas9 over existing alternatives.

    The objective of this study is to explore the market and patenting activity in CRISPR-Cas9 gene editing technology. This study considers issued patents and pending published applications related to
    CRISPR-Cas9 published since January 1, 2007. Search strategies using various combinations of keywords, classification codes, and prominent assignees resulted in more than 10K patent families. The hits were then refined by semi-automated techniques to arrive at 4800 unique patent applications that spread across ~1750 INPADOC families. These 1750 patent families were analyzed for trends and patterns to identify IP investment, key players, licensing activity and prolific inventors.

    Contact us at bd@maxval-ip.com for your custom patent landscape analysis needs.

    Go Back to Homepage

    Recent advances in Life Sciences | May 2018 Newsletter | MaxVal
    Hot Topics in Tech | June 2018 Newsletter | Maxval

    About Author

    MaxVal
    MaxVal

    Related Posts
    MaxVal Sponsoring and Exhibiting at Upcoming Conferences
    MaxVal Sponsoring and Exhibiting at Upcoming Conferences
    Generic Players to Benefit from Paragraph IV Approvals amidst FDA’s Push for Transparency and Competition
    Generic Players to Benefit from Paragraph IV Approvals amidst FDA’s Push for Transparency and Competition
    MaxVal expands with new Professional Services Organization
    MaxVal expands with new Professional Services Organization

    Comment

    Subscribe To Blog

    Subscribe to Email Updates